| Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study R Hisada, M Kato, E Sugawara, Y Fujieda, K Oku, T Bohgaki, O Amengual, ... Journal of thrombosis and haemostasis 15 (9), 1782-1787, 2017 | 55 | 2017 |
| Autophagy promotes citrullination of VIM (vimentin) and its interaction with major histocompatibility complex class II in synovial fibroblasts E Sugawara, M Kato, Y Kudo, W Lee, R Hisada, Y Fujieda, K Oku, ... Autophagy 16 (5), 946-955, 2020 | 39 | 2020 |
| Effects of statins on thrombosis development in patients with systemic lupus erythematosus and antiphospholipid antibodies T Watanabe, K Oku, O Amengual, R Hisada, K Ohmura, I Nakagawa, ... Lupus 27 (2), 225-234, 2018 | 35 | 2018 |
| Autoantibodies against a complement component 1 q subcomponent contribute to complement activation and recurrent thrombosis/pregnancy morbidity in anti-phospholipid syndrome K Oku, O Amengual, R Hisada, K Ohmura, I Nakagawa, T Watanabe, ... Rheumatology 55 (8), 1403-1411, 2016 | 33 | 2016 |
| Circulating plasmablasts contribute to antiphospholipid antibody production, associated with type I interferon upregulation R Hisada, M Kato, E Sugawara, M Kanda, Y Fujieda, K Oku, T Bohgaki, ... Journal of thrombosis and haemostasis 17 (7), 1134-1143, 2019 | 30 | 2019 |
| Efficacy of dual antiplatelet therapy for preventing recurrence of arterial thrombosis in patients with antiphospholipid syndrome N Ohnishi, Y Fujieda, R Hisada, H Nakamura, M Kato, K Oku, T Bohgaki, ... Rheumatology 58 (6), 969-974, 2019 | 30 | 2019 |
| Post-steroid neuropsychiatric manifestations are significantly more frequent in SLE compared with other systemic autoimmune diseases and predict better prognosis compared with … Y Shimizu, S Yasuda, Y Kako, S Nakagawa, M Kanda, R Hisada, ... Autoimmunity Reviews 15 (8), 786-794, 2016 | 28 | 2016 |
| Antiphospholipid score is a novel risk factor for idiopathic osteonecrosis of the femoral head in patients with systemic lupus erythematosus R Hisada, M Kato, N Ohnishi, E Sugawara, Y Fujieda, K Oku, T Bohgaki, ... Rheumatology 58 (4), 645-649, 2019 | 27 | 2019 |
| Pathogenic roles of anti-C1q antibodies in recurrent pregnancy loss K Ohmura, K Oku, T Kitaori, O Amengual, R Hisada, M Kanda, Y Shimizu, ... Clinical Immunology 203, 37-44, 2019 | 20 | 2019 |
| Clinical significance of plasma presepsin levels in patients with systemic lupus erythematosus S Tanimura, Y Fujieda, M Kono, Y Shibata, R Hisada, E Sugawara, ... Modern Rheumatology 28 (5), 865-871, 2018 | 19 | 2018 |
| Clinical profiles and risk assessment in patients with antiphospholipid antibodies M Kato, R Hisada, T Atsumi Expert review of clinical immunology 15 (1), 73-81, 2019 | 15 | 2019 |
| Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease Y Fujieda, T Asaka, M Ota, R Hisada, N Ohnishi, M Kono, H Kameda, ... Journal of Bone and Mineral Metabolism 38 (4), 581-588, 2020 | 14 | 2020 |
| Intertwined pathways of complement activation command the pathogenesis of lupus nephritis A Satyam, R Hisada, R Bhargava, MG Tsokos, GC Tsokos Translational Research, 2022 | 13 | 2022 |
| Treatment of vasodilator-resistant mixed connective tissue disease-associated pulmonary arterial hypertension with glucocorticoid and cyclophosphamide E Sugawara, M Kato, R Hisada, K Oku, T Bohgaki, T Horita, S Yasuda, ... Internal medicine 56 (4), 445-448, 2017 | 10 | 2017 |
| Glutaminase 2 Promotes Interleukin‐2 Production in CD4+ T cells by Supporting Antioxidant Defense R Hisada, N Yoshida, SYK Orite, M Umeda, C Burbano, M Scherlinger, ... Arthritis & Rheumatology, 2022 | 9* | 2022 |
| Anti-cyclic citrullinated peptide antibody titers decrease in rheumatoid arthritis patients treated with tocilizumab: a pilot study A Noguchi, S Yasuda, R Hisada, M Kato, K Oku, T Bohgaki, M Suzuki, ... Modern rheumatology 30 (2), 276-281, 2020 | 9 | 2020 |
| Calcineurin inhibitors for adult-onset Still's disease: a multicentre retrospective cohort study H Nakamura, Y Fujieda, M Tarumi, H Kitakawa, R Hisada, I Nakagawa, ... Clin Exp Rheumatol 38 (127), S11-S16, 2020 | 9 | 2020 |
| ADAM9 enhances Th17 cell differentiation and autoimmunity by activating TGF-β1 M Umeda, N Yoshida, R Hisada, C Burbano, SYK Orite, M Kono, ... Proceedings of the National Academy of Sciences 118 (18), 2021 | 8 | 2021 |
| Giant cell arteritis. S Jodo, R Hisada Nihon Rinsho Men'eki Gakkai Kaishi= Japanese Journal of Clinical Immunology …, 2013 | 5 | 2013 |
| Diversity of borderline pulmonary arterial pressure associated with systemic sclerosis: 3 case series E Sugawara, M Kato, T Sato, K Takahashi, M Kono, R Hisada, M Kono, ... Modern Rheumatology Case Reports 1 (1), 9-14, 2017 | 4 | 2017 |
